Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BUB1 | O43683 | 1/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | ACLY | P53396 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31729934 | 0.86 | BUB1 (0.37) | BUB1ACLYBCHEHTR6L3MBTL1 | |
| SCHEMBL31729948 | 0.85 | BUB1 (0.38) | BUB1PDE4DACLYBCHEHTR6 | |
| SCHEMBL31317119 | 0.85 | PDE4D (0.33) | BUB1PDE4DACLYBCHE | |
| SCHEMBL15366200 | 0.85 | PDE4D (0.33) | BUB1PDE4DACLYBCHE | |
| SCHEMBL31317212 | 0.84 | PDE4D (0.33) | BUB1PDE4DACLYBCHEHSP90AA1 | |
| SCHEMBL18683189 | 0.84 | PDE4D (0.33) | BUB1PDE4DACLYBCHE | |
| SCHEMBL15366333 | 0.84 | PDE4D (0.33) | BUB1PDE4DACLYBCHE | |
| SCHEMBL15366332 | 0.84 | PDE4D (0.33) | BUB1PDE4DACLYBCHE | |
| SCHEMBL31729933 | 0.83 | BUB1 (0.37) | BUB1PDE4DACLYBCHEHTR6 | |
| SCHEMBL31549571 | 0.82 | BUB1 (0.44) | BUB1ACLYBCHEHTR6L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4650351-A1 | INHIBITOR OF COMPLEMENT FACTOR B | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (CN) | 2025-11-19 | — | — | EP | disclosed |
| WO-2024149261-A1 | INHIBITOR OF COMPLEMENT FACTOR B | 南京正大天晴制药有限公司 | 2024-07-18 | — | — | WO | disclosed |